Readmission Reduction with Advanced Knees/Feet: Economic Case for CMOs

Readmission Reduction with Advanced Knees/Feet: Economic Case for CMOs

Hospital leaders today are under pressure from all sides. Readmissions hurt patient trust, strain care teams, and quietly drain hospital revenue. For Chief Medical Officers, the challenge is not only to improve outcomes, but to do it in a way that makes financial sense. One area that often gets overlooked is prosthetic care, especially the role of advanced knees and feet in reducing avoidable readmissions.

This article looks at a simple but powerful idea. When patients with limb loss receive better mobility support, they fall less, heal faster, and return to the hospital less often. Advanced prosthetic knees and feet are not just clinical upgrades. They are economic tools that can protect margins while improving lives.

In the sections ahead, we will break down how readmissions happen, why basic prosthetics increase risk, and how modern knees and feet change the story. The goal is to give CMOs a clear, practical case for investing in better prosthetic technology, with real-world insight, not theory.

The Real Cost of Readmissions in Limb Loss Care

Readmissions Are More Than a Clinical Metric

For hospitals, readmissions are often discussed as numbers on a dashboard. A percentage here. A penalty there. But behind every readmission is a patient whose recovery did not go as planned.

In limb loss care, readmissions usually signal something very specific. A fall. A wound that did not heal. A device that failed the patient in daily life. These events are not random. They follow patterns.

When mobility is unsafe or tiring, patients limit movement. When they limit movement, their health declines. That decline often brings them back to the hospital.

Why CMOs Feel the Pressure the Most

Chief Medical Officers sit at the center of this problem. They are accountable for outcomes, safety, and quality, while also protecting the hospital from financial loss.

Readmission penalties reduce reimbursement. Longer stays increase cost. Staff burnout rises when the same patients return again and again.

For CMOs, the question becomes simple. Where can we reduce risk without adding complexity to care delivery?

Limb Loss Patients Are a High-Risk Group

Patients with amputations are more likely to be readmitted than many other groups. The reasons are not hard to see.

They are adjusting to a new body. They are learning to walk again. They often have diabetes or vascular disease. A small setback can quickly turn into a major event.

When prosthetic support is weak, the risk multiplies.

How Basic Prosthetics Increase Readmission Risk

Limited Stability Leads to Falls

Basic prosthetic knees and feet are often chosen

Basic prosthetic knees and feet are often chosen because they are cheaper upfront. But these devices usually lack adaptive control.

They do not adjust to walking speed. They do not respond well to slopes or uneven ground. They offer little protection when a patient stumbles.

Falls are one of the top causes of readmission in amputee patients. A single fall can mean fractures, head injury, or surgical revision.

Higher Energy Use Slows Recovery

Simple prosthetic systems require more effort to use. Patients must compensate with their hips, back, and sound limb.

This higher energy use causes fatigue. Fatigue reduces activity. Reduced activity slows healing and increases the risk of infection.

When recovery stalls, patients often return with complications that could have been avoided.

Poor Confidence Changes Behavior

Mobility is not only physical. It is also mental.

When patients do not trust their prosthetic leg, they move less. They avoid stairs. They avoid longer walks. Some stop using the device altogether.

This loss of confidence leads to isolation, weight gain, and decline in overall health. These factors quietly increase the chance of readmission.

Understanding Advanced Prosthetic Knees and Feet

What Makes These Devices Different

Advanced knees and feet are designed to respond to the user, not fight them.

They use sensors to detect movement. They adjust resistance in real time. They provide smoother walking and safer stance control.

Instead of forcing the patient to adapt to the device, the device adapts to the patient.

Stability Across Real-World Situations

One major advantage is stability in daily life.

Advanced knees can sense when a patient is standing, walking, or changing speed. They lock when needed and release smoothly when safe.

Advanced feet provide better ground contact. They adjust to slopes, uneven surfaces, and changes in direction.

This stability directly reduces fall risk.

Lower Physical Strain on the Body

Because these devices move more naturally, patients use less energy to walk.

Reduced strain means less stress on joints and the lower back. It also means patients can walk longer without pain.

More movement supports better circulation, faster healing, and stronger overall health.

The Direct Link Between Mobility and Readmissions

Fewer Falls Mean Fewer Emergency Visits

The most immediate impact of advanced knees and feet is fall prevention.

When patients feel stable, they recover faster and move with confidence. Emergency visits drop. Trauma-related readmissions fall.

For hospitals, this alone can justify the investment.

Better Healing Through Consistent Movement

Movement plays a key role in recovery. It supports wound healing, muscle strength, and mental health.

Advanced prosthetics encourage regular use. Patients walk more. They stay active.

This consistency reduces post-surgical complications and lowers the chance of infection-related readmissions.

Improved Compliance With Rehabilitation

When prosthetic walking feels smoother, patients engage more in rehab.

They attend therapy sessions. They practice at home. They progress faster.

Stronger rehab outcomes reduce long-term dependency on hospital services.

The Economic Case CMOs Need to See

Upfront Cost Versus Downstream Savings

Advanced prosthetic knees and feet cost more at the start. This is often where the conversation stops.

But readmissions are expensive. Falls are expensive. Long stays are expensive.

When one avoids even a single readmission, the cost difference begins to narrow. Over time, it often disappears.

Reduced Length of Stay

Patients who mobilize early and safely are discharged sooner.

Advanced prosthetics support early ambulation. This shortens hospital stays and frees up beds.

For CMOs managing capacity, this benefit is significant.

Lower Burden on Care Teams

Fewer complications mean fewer emergency calls, fewer revisions, and less stress on staff.

Care teams can focus on new patients instead of managing preventable setbacks.

This improves morale and care quality at the same time.

Why This Decision Aligns With Value-Based Care

Outcomes Matter More Than Devices

Value-based care rewards results, not tools.

Advanced knees and feet are not about technology for its own sake. They are about reducing harm and improving function.

Better mobility outcomes align directly with quality metrics hospitals are measured on.

Patient Satisfaction Scores Improve

Patients who walk safely and independently report higher satisfaction.

They feel supported. They feel respected. They feel confident leaving the hospital.

These experiences reflect in feedback scores and public ratings.

Long-Term Population Health Benefits

When amputee patients stay active, their overall health improves.

They manage chronic disease better. They rely less on acute care. They stay out of the hospital.

This supports long-term population health goals.

Making the Shift From Basic to Advanced Prosthetics

Why Change Feels Risky Inside Hospitals

Any change in clinical practice brings hesitation. Prosthetic upgrades are often seen as non-essential, especially when budgets are tight.

Many teams worry about cost approvals, training needs, and pushback from finance departments. There is also fear of disrupting existing vendor relationships.

For CMOs, the risk feels personal. If outcomes do not improve quickly, the decision may be questioned.

Reframing Prosthetics as Preventive Care

The first shift is mental. Advanced knees and feet should not be viewed as equipment upgrades.

They are preventive tools. Just like infection control or fall prevention programs.

When framed this way, the conversation changes from expense to risk reduction.

Using Readmission Data to Build the Case

Most hospitals already track readmissions by diagnosis and cause.

Falls, wound issues, and mobility-related complications often appear again and again in amputee cases.

By linking these events to prosthetic limitations, CMOs can present a data-backed story, not an opinion.

Internal Alignment: Getting Stakeholders on Board

Engaging Orthopedics and Rehabilitation Teams

Surgeons and therapists see the daily struggles of amputee patients.

They witness unsafe gait, fear of walking, and slow rehab progress.

Including them early builds clinical support. Their voices carry weight in decision-making rooms.

Working With Finance Without Conflict

Finance teams focus on numbers, not narratives.

Presenting a simple comparison helps. One advanced prosthetic versus one avoided readmission.

When numbers are clear and conservative, resistance often softens.

Addressing Procurement Concerns Early

Procurement teams worry about contracts, vendors, and compliance.

Early engagement helps avoid last-minute delays.

Clear criteria for patient selection and device use also reduce fear of uncontrolled spending.

Selecting the Right Patients for Maximum Impact

Not Every Patient Needs Advanced Devices

Advanced knees and feet are powerful, but they are not needed for everyone.

CMOs can guide teams to focus on patients with the highest readmission risk.

This targeted approach improves outcomes while controlling cost.

High-Risk Profiles to Prioritize

Patients with diabetes, vascular disease, or previous falls benefit the most.

So do patients living alone or returning to uneven environments.

These individuals are more likely to return if mobility fails.

Timing Matters More Than Severity

Early fitting with advanced prosthetics leads to better results.

Waiting until problems appear often means readmission has already happened.

Proactive decisions create stronger long-term outcomes.

Implementation Without Disrupting Care Flow

Integrating Into Existing Care Pathways

Advanced prosthetics do not require a new care model.

They fit into existing post-surgical and rehab workflows.

The key is coordination, not reinvention.

Training Is Simpler Than Expected

Modern prosthetic systems are designed for ease of use.

Most rehab teams adapt quickly with minimal training.

Vendors often support onboarding, reducing the burden on hospital staff.

Monitoring Outcomes From Day One

Tracking simple metrics builds confidence.

Falls, length of stay, rehab progress, and readmission rates tell the story clearly.

Early wins help sustain internal support.

Addressing Common Objections Head-On

“The Cost Is Too High”

This concern is common and understandable.

But when costs are compared to penalties, extended stays, and repeat admissions, the picture changes.

Advanced prosthetics shift spending from reactive to preventive.

“Our Patients Won’t Adapt”

Evidence shows the opposite.

Patients adapt faster to devices that feel natural and stable.

Confidence grows when the device supports, not challenges, movement.

“We Already Have a Prosthetic Vendor”

Vendor loyalty is important, but outcomes matter more.

Many advanced solutions can integrate into existing partnerships.

The goal is better care, not disruption.

Long-Term Impact on Hospital Performance

Sustained Reduction in Readmissions

Once advanced prosthetics become part of care strategy, results compound.

Fewer falls lead to fewer emergencies.

Fewer emergencies lead to lower readmission rates year after year.

Stronger Reputation for Quality Care

Hospitals known for better amputee outcomes attract referrals.

Physicians trust systems that invest in patient safety.

Patients talk about experiences that restore dignity and independence.

Supporting the CMO’s Strategic Vision

This approach aligns clinical quality with financial responsibility.

It shows leadership that values prevention, not just treatment.

For CMOs, it strengthens both outcomes and credibility.

The Human Side of the Economic Argument

Beyond Numbers and Spreadsheets

At the heart of this discussion are people learning to walk again.

Every avoided fall protects more than a budget line.

It protects confidence, independence, and hope.

Mobility as a Measure of Respect

Providing better mobility tools sends a message.

It says the hospital believes the patient deserves safety and dignity.

That message stays long after discharge.

When Economics and Ethics Align

Few decisions offer both financial and moral clarity.

Advanced knees and feet do exactly that.

They reduce cost while improving lives.

Real-World Outcomes That Change the Conversation

What Hospitals See After the Shift

When hospitals move from basic to advanced knees and feet

When hospitals move from basic to advanced knees and feet, the change is often quiet at first.

There is no big announcement. No sudden spike in numbers.

Instead, teams notice fewer emergency calls. Fewer reports of falls. Fewer unplanned returns.

Over months, patterns become clear. The same patients who once came back now stay home and recover.

The Difference Shows Up in Rehab Rooms

Rehabilitation teams are often the first to notice change.

Patients stand sooner. Walking sessions last longer. Fear reduces.

Therapists spend less time correcting unsafe gait and more time building strength and confidence.

This shift improves both efficiency and morale inside rehab departments.

Families Notice Before Data Does

Family members often see the impact before metrics do.

They report fewer stumbles at home. Less anxiety about daily tasks.

When families feel safer, they are less likely to bring patients back for minor concerns that escalate into admissions.

Case Patterns Seen Across Care Settings

Acute Care Hospitals

In acute settings, early mobility is critical.

Advanced knees support safer transfers, bathroom use, and corridor walking.

This reduces in-hospital falls, which are a major driver of extended stays and legal risk.

Early success sets the tone for the entire recovery journey.

Post-Acute and Rehab Centers

Rehab centers often deal with setbacks caused by unstable prosthetics.

Advanced systems reduce interruptions in therapy.

Fewer pauses mean faster functional gains and earlier discharge to home.

This improves throughput and resource use.

Community and Home-Based Recovery

The real test of any prosthetic is life outside the hospital.

Uneven roads, stairs, wet floors, and crowds are daily challenges.

Advanced knees and feet handle these conditions better, reducing community-based readmissions.

Policy and Payment Trends CMOs Should Watch

Movement Toward Outcome-Based Reimbursement

Health systems are steadily moving away from volume-based models.

Readmission rates, functional outcomes, and patient experience are gaining weight.

Advanced prosthetics directly influence these measures.

Early adoption prepares hospitals for future payment structures.

Growing Focus on Fall Prevention

Falls are now a major quality indicator.

Regulators and payers track fall-related harm closely.

Investing in mobility technology is a proactive fall prevention strategy.

Prosthetics as Part of Continuum of Care

Policy discussions increasingly include prosthetics as part of long-term care planning.

CMOs who integrate prosthetic strategy early align with this broader view.

This reduces fragmentation and improves continuity.

Measuring Success Without Overcomplication

Start With Simple Metrics

Measurement does not need to be complex.

Track falls, length of stay, readmissions, and rehab milestones.

These indicators already exist in most systems.

The difference lies in connecting them to prosthetic choice.

Compare Similar Patient Groups

To show impact clearly, compare similar cases.

Patients with similar diagnoses, age, and risk profiles.

One group with basic devices. One with advanced.

Even small sample sizes often show meaningful trends.

Use Stories Alongside Numbers

Data convinces finance teams. Stories convince leadership.

Sharing patient journeys helps humanize the metrics.

Together, they create a complete picture.

Building a Long-Term Prosthetic Strategy

Moving Beyond One-Time Decisions

Advanced prosthetics should not be a one-off experiment.

They work best as part of a defined care pathway.

Clear guidelines help teams make consistent choices.

Creating Clinical Criteria

Develop simple criteria for device selection.

Risk of falls. Living environment. Medical history.

This removes guesswork and ensures fair access.

Partnering With the Right Manufacturers

Reliability matters.

Devices must be durable, serviceable, and supported locally.

Strong partnerships reduce downtime and patient frustration.

Addressing Equity and Access Concerns

Advanced Does Not Have to Mean Exclusive

One fear is that advanced devices create inequality.

This happens only when selection lacks structure.

Clear criteria ensure those who benefit most receive priority.

Supporting Patients From Diverse Backgrounds

Many amputee patients come from working-class environments.

They face uneven roads, public transport, and physical jobs.

Advanced knees and feet offer protection in these real conditions.

Reducing Long-Term Social Cost

When patients remain mobile, they stay employed longer.

They rely less on caregivers and social services.

This reduces burden beyond the hospital walls.

The Role of the CMO as a Change Leader

Setting the Vision

CMOs shape how quality is defined.

By linking mobility to safety and outcomes, they elevate prosthetic care.

This sets expectations across departments.

Encouraging Cross-Team Collaboration

Prosthetic decisions touch surgery, rehab, nursing, and finance.

CMOs can bring these voices together.

Shared ownership leads to smoother implementation.

Standing Behind Preventive Investments

Not all benefits appear in one quarter.

Leadership commitment allows programs time to mature.

The long-term gains often outweigh early hesitation.

When Doing the Right Thing Makes Business Sense

A Rare Alignment of Goals

Few interventions improve outcomes, reduce cost, and raise satisfaction at once.

Advanced knees and feet do exactly that.

They address a root cause, not a symptom.

Protecting the Hospital’s Future

As care models evolve, hospitals that prevent harm will lead.

Reducing avoidable readmissions strengthens resilience.

It prepares systems for tighter margins ahead.

Leaving a Legacy of Better Care

For CMOs, impact is measured in systems built, not meetings attended.

Embedding better mobility support changes countless lives.

That legacy lasts far beyond annual reports.

How CMOs Can Make Confident Executive Decisions

Shifting the Question From “Can We Afford This?” to “Can We Afford Not To?”

At the executive level, decisions often stall because the wrong question is asked. Advanced knees and feet are usually evaluated as line-item costs instead of risk-control tools. This framing limits the discussion before it begins.

A better question is whether the hospital can afford repeated readmissions, longer stays, fall-related injuries, and avoidable complications in amputee care. When mobility-related readmissions are mapped across a year, the hidden cost becomes visible.

Once leaders see prosthetics as part of patient safety strategy, not equipment spend, approval becomes easier and more rational.

Balancing Clinical Judgment With Financial Stewardship

CMOs often sit between two strong forces. Clinical teams push for better tools, while finance teams push for tighter controls. The role of the CMO is not to choose one side, but to translate between them.

Advanced prosthetics offer a rare bridge. Clinically, they improve safety, confidence, and rehab outcomes. Financially, they reduce downstream events that cost far more than the device itself.

This balance strengthens the CMO’s position as both a care leader and a responsible steward.

Using Pilot Programs to Reduce Perceived Risk

One of the most effective ways to move forward is through small, controlled pilots. Instead of a full rollout, hospitals can start with a defined group of high-risk amputee patients.

Tracking outcomes over six to nine months often provides enough internal evidence to justify expansion. Pilots lower fear, create internal champions, and replace assumptions with real data from the hospital’s own patients.

Creating Simple Frameworks That Teams Can Follow

Clear Guidelines Prevent Inconsistent Decisions

Without structure, prosthetic selection becomes subjective. This leads to confusion, delays, and uneven patient outcomes.

CMOs can support the creation of simple clinical guidelines that define when advanced knees or feet are recommended. These guidelines should be based on fall risk, environment, medical history, and rehab potential.

When teams know the criteria, decisions become faster and fairer.

Aligning Surgeons, Therapists, and Discharge Teams

Advanced prosthetic outcomes depend on timing and coordination. Surgeons, rehab teams, and discharge planners must work from the same playbook.

When prosthetic planning starts early, patients mobilize sooner and discharge planning becomes smoother. Late decisions often lead to rushed fittings and poor adaptation, which increase readmission risk.

Strong alignment reduces friction and improves continuity of care.

Documenting Decisions for Long-Term Learning

Each advanced prosthetic case is an opportunity to learn. Simple documentation of why a device was chosen and how the patient progressed builds institutional knowledge.

Over time, this record helps refine criteria, justify budgets, and train new staff. It turns individual decisions into system-wide improvement.

The Financial Impact Over Time, Not Just One Quarter

How Savings Accumulate Quietly

The financial benefit of advanced knees and feet rarely appears as a single large number. Instead, it shows up as absence. Fewer emergency visits. Fewer revision surgeries. Fewer extended stays.

These avoided costs accumulate month by month. By the end of a year, the difference is often significant, even if it was not dramatic in any single report.

CMOs who look beyond quarterly snapshots see the real value.

Reducing Unplanned Resource Use

Unplanned care is the most expensive kind of care. It disrupts schedules, overloads staff, and strains budgets.

By stabilizing mobility, advanced prosthetics reduce surprises. Care becomes more predictable, which improves planning and cost control across departments.

Predictability is an underrated financial advantage.

Supporting Sustainable Growth

Hospitals that manage readmissions well can focus on growth instead of damage control. Beds open up. Staff time is freed. Reputation improves.

Advanced prosthetics contribute to this stability by reducing preventable setbacks in a high-risk group.

The Ethical Dimension CMOs Cannot Ignore

Preventable Harm Is Still Harm

When a patient falls because their prosthetic

When a patient falls because their prosthetic could not support them, the harm is preventable. That reality weighs heavily on clinical leaders.

Advanced knees and feet reduce known risks. Choosing not to use them when appropriate raises ethical questions, not just financial ones.

CMOs are often the voice of this responsibility.

Dignity as a Clinical Outcome

Mobility is tied to dignity. Patients who can walk safely feel respected and capable.

Hospitals that invest in better mobility tools send a strong message about the kind of care they provide. This message matters to patients, families, and staff alike.

Trust Built Through Better Outcomes

Trust grows when patients feel protected after discharge. Fewer returns mean stronger belief in the system.

That trust has long-term value that cannot be measured only in currency.

A Practical Next-Step Checklist for CMOs

Start With Data You Already Have

Most hospitals already track the metrics needed to begin. Readmissions, falls, length of stay, and rehab delays are already documented.

The first step is connecting these outcomes to prosthetic limitations.

Identify a High-Risk Patient Group

Choose a small group where impact is likely. Patients with prior falls, complex environments, or slow rehab progress are ideal starting points.

Targeted use delivers faster results and clearer evidence.

Build a Cross-Functional Working Group

Include orthopedics, rehab, nursing, finance, and procurement. Early collaboration prevents late-stage resistance.

Shared ownership increases success.

Measure, Review, and Adjust

Track outcomes regularly and review them openly. Adjust criteria as needed.

This iterative approach builds confidence and momentum.

Closing the Gap Between Cost and Care

Advanced prosthetic knees and feet are not luxury items. They are safety tools, rehab enablers, and cost-control mechanisms wrapped into one.

For CMOs, the decision is not about technology. It is about reducing preventable harm while protecting the hospital’s future.

When patients walk safely, systems work better. Readmissions fall. Costs stabilize. Trust grows.

In a healthcare environment under constant pressure, few decisions offer such clear alignment between clinical excellence and economic sense.

Share:

More Posts

Partner With Us

REFUNDS AND CANCELLATIONS

Last updated: November 10, 2022

Thank you for shopping at Robo Bionics.

If, for any reason, You are not completely satisfied with a purchase We invite You to review our policy on refunds and returns.

The following terms are applicable for any products that You purchased with Us.

Interpretation And Definitions

Interpretation

The words of which the initial letter is capitalized have meanings defined under the following conditions. The following definitions shall have the same meaning regardless of whether they appear in singular or in plural.

Definitions

For the purposes of this Return and Refund Policy:

  • Company (referred to as either “the Company”, “Robo Bionics”, “We”, “Us” or “Our” in this Agreement) refers to Bionic Hope Private Limited, Pearl Haven, 1st Floor Kumbharwada, Manickpur Near St. Michael’s Church Vasai Road West, Palghar Maharashtra 401202.

  • Goods refer to the items offered for sale on the Website.

  • Orders mean a request by You to purchase Goods from Us.

  • Service refers to the Services Provided like Online Demo and Live Demo.

  • Website refers to Robo Bionics, accessible from https://robobionics.in

  • You means the individual accessing or using the Service, or the company, or other legal entity on behalf of which such individual is accessing or using the Service, as applicable.

Your Order Cancellation Rights

You are entitled to cancel Your Service Bookings within 7 days without giving any reason for doing so, before completion of Delivery.

The deadline for cancelling a Service Booking is 7 days from the date on which You received the Confirmation of Service.

In order to exercise Your right of cancellation, You must inform Us of your decision by means of a clear statement. You can inform us of your decision by:

  • By email: contact@robobionics.in

We will reimburse You no later than 7 days from the day on which We receive your request for cancellation, if above criteria is met. We will use the same means of payment as You used for the Service Booking, and You will not incur any fees for such reimbursement.

Please note in case you miss a Service Booking or Re-schedule the same we shall only entertain the request once.

Conditions For Returns

In order for the Goods to be eligible for a return, please make sure that:

  • The Goods were purchased in the last 14 days
  • The Goods are in the original packaging

The following Goods cannot be returned:

  • The supply of Goods made to Your specifications or clearly personalized.
  • The supply of Goods which according to their nature are not suitable to be returned, deteriorate rapidly or where the date of expiry is over.
  • The supply of Goods which are not suitable for return due to health protection or hygiene reasons and were unsealed after delivery.
  • The supply of Goods which are, after delivery, according to their nature, inseparably mixed with other items.

We reserve the right to refuse returns of any merchandise that does not meet the above return conditions in our sole discretion.

Only regular priced Goods may be refunded by 50%. Unfortunately, Goods on sale cannot be refunded. This exclusion may not apply to You if it is not permitted by applicable law.

Returning Goods

You are responsible for the cost and risk of returning the Goods to Us. You should send the Goods at the following:

  • the Prosthetic Limb Fitting Centre that they purchased the product from
  • email us at contact@robobionics.in with all the information and we shall provide you a mailing address in 3 days.

We cannot be held responsible for Goods damaged or lost in return shipment. Therefore, We recommend an insured and trackable courier service. We are unable to issue a refund without actual receipt of the Goods or proof of received return delivery.

Contact Us

If you have any questions about our Returns and Refunds Policy, please contact us:

  • By email: contact@robobionics.in

TERMS & CONDITIONS

Last Updated on: 1st Jan 2021

These Terms and Conditions (“Terms”) govern Your access to and use of the website, platforms, applications, products and services (ively, the “Services”) offered by Robo Bionics® (a registered trademark of Bionic Hope Private Limited, also used as a trade name), a company incorporated under the Companies Act, 2013, having its Corporate office at Pearl Heaven Bungalow, 1st Floor, Manickpur, Kumbharwada, Vasai Road (West), Palghar – 401202, Maharashtra, India (“Company”, “We”, “Us” or “Our”). By accessing or using the Services, You (each a “User”) agree to be bound by these Terms and all applicable laws and regulations. If You do not agree with any part of these Terms, You must immediately discontinue use of the Services.

1. DEFINITIONS

1.1 “Individual Consumer” means a natural person aged eighteen (18) years or above who registers to use Our products or Services following evaluation and prescription by a Rehabilitation Council of India (“RCI”)–registered Prosthetist.

1.2 “Entity Consumer” means a corporate organisation, nonprofit entity, CSR sponsor or other registered organisation that sponsors one or more Individual Consumers to use Our products or Services.

1.3 “Clinic” means an RCI-registered Prosthetics and Orthotics centre or Prosthetist that purchases products and Services from Us for fitment to Individual Consumers.

1.4 “Platform” means RehabConnect, Our online marketplace by which Individual or Entity Consumers connect with Clinics in their chosen locations.

1.5 “Products” means Grippy® Bionic Hand, Grippy® Mech, BrawnBand, WeightBand, consumables, accessories and related hardware.

1.6 “Apps” means Our clinician-facing and end-user software applications supporting Product use and data collection.

1.7 “Impact Dashboard™” means the analytics interface provided to CSR, NGO, corporate and hospital sponsors.

1.8 “Services” includes all Products, Apps, the Platform and the Impact Dashboard.

2. USER CATEGORIES AND ELIGIBILITY

2.1 Individual Consumers must be at least eighteen (18) years old and undergo evaluation and prescription by an RCI-registered Prosthetist prior to purchase or use of any Products or Services.

2.2 Entity Consumers must be duly registered under the laws of India and may sponsor one or more Individual Consumers.

2.3 Clinics must maintain valid RCI registration and comply with all applicable clinical and professional standards.

3. INTERMEDIARY LIABILITY

3.1 Robo Bionics acts solely as an intermediary connecting Users with Clinics via the Platform. We do not endorse or guarantee the quality, legality or outcomes of services rendered by any Clinic. Each Clinic is solely responsible for its professional services and compliance with applicable laws and regulations.

4. LICENSE AND INTELLECTUAL PROPERTY

4.1 All content, trademarks, logos, designs and software on Our website, Apps and Platform are the exclusive property of Bionic Hope Private Limited or its licensors.

4.2 Subject to these Terms, We grant You a limited, non-exclusive, non-transferable, revocable license to use the Services for personal, non-commercial purposes.

4.3 You may not reproduce, modify, distribute, decompile, reverse engineer or create derivative works of any portion of the Services without Our prior written consent.

5. WARRANTIES AND LIMITATIONS

5.1 Limited Warranty. We warrant that Products will be free from workmanship defects under normal use as follows:
 (a) Grippy™ Bionic Hand, BrawnBand® and WeightBand®: one (1) year from date of purchase, covering manufacturing defects only.
 (b) Chargers and batteries: six (6) months from date of purchase.
 (c) Grippy Mech™: three (3) months from date of purchase.
 (d) Consumables (e.g., gloves, carry bags): no warranty.

5.2 Custom Sockets. Sockets fabricated by Clinics are covered only by the Clinic’s optional warranty and subject to physiological changes (e.g., stump volume, muscle sensitivity).

5.3 Exclusions. Warranty does not apply to damage caused by misuse, user negligence, unauthorised repairs, Acts of God, or failure to follow the Instruction Manual.

5.4 Claims. To claim warranty, You must register the Product online, provide proof of purchase, and follow the procedures set out in the Warranty Card.

5.5 Disclaimer. To the maximum extent permitted by law, all other warranties, express or implied, including merchantability and fitness for a particular purpose, are disclaimed.

6. DATA PROTECTION AND PRIVACY

6.1 We collect personal contact details, physiological evaluation data, body measurements, sensor calibration values, device usage statistics and warranty information (“User Data”).

6.2 User Data is stored on secure servers of our third-party service providers and transmitted via encrypted APIs.

6.3 By using the Services, You consent to collection, storage, processing and transfer of User Data within Our internal ecosystem and to third-party service providers for analytics, R&D and support.

6.4 We implement reasonable security measures and comply with the Information Technology Act, 2000, and Information Technology (Reasonable Security Practices and Procedures and Sensitive Personal Data or Information) Rules, 2011.

6.5 A separate Privacy Policy sets out detailed information on data processing, user rights, grievance redressal and cross-border transfers, which forms part of these Terms.

7. GRIEVANCE REDRESSAL

7.1 Pursuant to the Information Technology Rules, 2021, We have given the Charge of Grievance Officer to our QC Head:
 - Address: Grievance Officer
 - Email: support@robobionics.in
 - Phone: +91-8668372127

7.2 All support tickets and grievances must be submitted exclusively via the Robo Bionics Customer Support portal at https://robobionics.freshdesk.com/.

7.3 We will acknowledge receipt of your ticket within twenty-four (24) working hours and endeavour to resolve or provide a substantive response within seventy-two (72) working hours, excluding weekends and public holidays.

8. PAYMENT, PRICING AND REFUND POLICY

8.1 Pricing. Product and Service pricing is as per quotations or purchase orders agreed in writing.

8.2 Payment. We offer (a) 100% advance payment with possible incentives or (b) stage-wise payment plans without incentives.

8.3 Refunds. No refunds, except pro-rata adjustment where an Individual Consumer is medically unfit to proceed or elects to withdraw mid-stage, in which case unused stage fees apply.

9. USAGE REQUIREMENTS AND INDEMNITY

9.1 Users must follow instructions provided by RCI-registered professionals and the User Manual.

9.2 Users and Entity Consumers shall indemnify and hold Us harmless from all liabilities, claims, damages and expenses arising from misuse of the Products, failure to follow professional guidance, or violation of these Terms.

10. LIABILITY

10.1 To the extent permitted by law, Our total liability for any claim arising out of or in connection with these Terms or the Services shall not exceed the aggregate amount paid by You to Us in the twelve (12) months preceding the claim.

10.2 We shall not be liable for any indirect, incidental, consequential or punitive damages, including loss of profit, data or goodwill.

11. MEDICAL DEVICE COMPLIANCE

11.1 Our Products are classified as “Rehabilitation Aids,” not medical devices for diagnostic purposes.

11.2 Manufactured under ISO 13485:2016 quality management and tested for electrical safety under IEC 60601-1 and IEC 60601-1-2.

11.3 Products shall only be used under prescription and supervision of RCI-registered Prosthetists, Physiotherapists or Occupational Therapists.

12. THIRD-PARTY CONTENT

We do not host third-party content or hardware. Any third-party services integrated with Our Apps are subject to their own terms and privacy policies.

13. INTELLECTUAL PROPERTY

13.1 All intellectual property rights in the Services and User Data remain with Us or our licensors.

13.2 Users grant Us a perpetual, irrevocable, royalty-free licence to use anonymised usage data for analytics, product improvement and marketing.

14. MODIFICATIONS TO TERMS

14.1 We may amend these Terms at any time. Material changes shall be notified to registered Users at least thirty (30) days prior to the effective date, via email and website notice.

14.2 Continued use of the Services after the effective date constitutes acceptance of the revised Terms.

15. FORCE MAJEURE

Neither party shall be liable for delay or failure to perform any obligation under these Terms due to causes beyond its reasonable control, including Acts of God, pandemics, strikes, war, terrorism or government regulations.

16. DISPUTE RESOLUTION AND GOVERNING LAW

16.1 All disputes shall be referred to and finally resolved by arbitration under the Arbitration and Conciliation Act, 1996.

16.2 A sole arbitrator shall be appointed by Bionic Hope Private Limited or, failing agreement within thirty (30) days, by the Mumbai Centre for International Arbitration.

16.3 Seat of arbitration: Mumbai, India.

16.4 Governing law: Laws of India.

16.5 Courts at Mumbai have exclusive jurisdiction over any proceedings to enforce an arbitral award.

17. GENERAL PROVISIONS

17.1 Severability. If any provision is held invalid or unenforceable, the remainder shall remain in full force.

17.2 Waiver. No waiver of any breach shall constitute a waiver of any subsequent breach of the same or any other provision.

17.3 Assignment. You may not assign your rights or obligations without Our prior written consent.

By accessing or using the Products and/or Services of Bionic Hope Private Limited, You acknowledge that You have read, understood and agree to be bound by these Terms and Conditions.